Blood Test Tracking for Uterine Fibroids

Heavy Menstrual Bleeding, Iron Depletion, and Why Haemoglobin Misses the Problem

Uterine fibroids affect up to approximately 70% of white women and over 80% of women of African descent by age 50, and heavy menstrual bleeding (menorrhagia) is reported by 30–40% of women with fibroids. This sustained monthly blood loss progressively depletes iron stores over months and years, leading to iron deficiency anaemia that is often gradual and insidious — meaning women adapt to worsening fatigue before any single result triggers clinical concern.

The key diagnostic insight is that ferritin falls well before haemoglobin does. A woman whose haemoglobin is 118 g/L — borderline but technically "normal" by many laboratory thresholds — may have a ferritin of 8 ng/mL, which indicates severely depleted iron stores and explains significant fatigue, reduced cognitive clarity, reduced exercise tolerance, and hair thinning. Tracking ferritin, not just the haemoglobin reported on a full blood count, gives a more sensitive and earlier warning of this depletion. The ferritin guide explains the thresholds that matter practically.

Serum iron assessed alongside ferritin provides a full iron panel view — capturing both circulating iron and stored reserves. When both are low, the case for iron supplementation or investigation of the underlying bleeding cause is stronger. The iron and anaemia topic page and the iron panel guide provide detailed context on interpreting this combination.

TSH, Thyroid Function, and the Link to Heavy Periods

Hypothyroidism is an independent cause of heavy menstrual bleeding through its effects on coagulation factor activity and sex hormone binding globulin. In women with known fibroids who are experiencing worsening menorrhagia, checking TSH is a clinically relevant step — not because thyroid dysfunction causes fibroids, but because untreated hypothyroidism can substantially worsen bleeding severity and the resulting anaemia on top of fibroid-driven blood loss.

The overlap in symptoms between iron deficiency anaemia and hypothyroidism — fatigue, heavy periods, weight gain, cold intolerance, and brain fog — makes distinguishing them through blood testing rather than symptom pattern alone important. A TSH check alongside a ferritin and iron panel provides a much more complete diagnostic picture. The thyroid blood tests guide explains what TSH results mean in practice, and the thyroid health topic in Health3 tracks TSH alongside related markers.

For women on GnRH agonist therapy (such as leuprolide) or selective progesterone receptor modulators as medical management for fibroids, blood monitoring recommendations — particularly for liver enzymes and haemoglobin — are determined by your treating clinician. Health3 can track any biomarker your provider orders, providing a longitudinal record of treatment response across the monitoring period.

Vitamin D, B12, Calcium, and Magnesium in Fibroid Management

An emerging area of research investigates the relationship between vitamin D and fibroid biology. Observational studies have found higher fibroid prevalence and larger fibroid volumes in women with lower vitamin D levels. Laboratory evidence suggests vitamin D may have antiproliferative effects on fibroid cells. This evidence is preliminary — research suggests an association and a plausible mechanism, but randomised trials are limited, and vitamin D supplementation is not a fibroid treatment. What is clear is that vitamin D deficiency is common, correctable, and has well-established benefits for immune function, bone health, and mood. The vitamin D guide explains what optimal levels mean in this context.

Women with significant anaemia from fibroid-related blood loss may also have B12 insufficiency compounding their anaemia, particularly those who eat little animal protein or have absorption limitations. B12 is required for red blood cell maturation, and its deficiency produces a macrocytic anaemia that can coexist with — and mask — the microcytic pattern of iron deficiency anaemia. The B vitamins guide covers the distinction.

Calcium and magnesium are relevant for women receiving GnRH agonist therapy, which induces a temporary hypoestrogenic state that can reduce bone density during the treatment period. Monitoring calcium and ensuring adequate magnesium intake supports bone health during therapy. Visit the bone health topic for a consolidated view of relevant markers.

Tracking Anaemia Severity and Treatment Response in Health3

Fibroid management typically unfolds over years — watchful waiting, medical management, and eventually procedural or surgical intervention — with blood tests ordered at intervals to monitor anaemia severity and treatment response. Health3 provides the longitudinal tracking layer that connects these interval tests into a meaningful narrative rather than isolated snapshots.

The trending view makes it immediately visible whether ferritin is recovering following iron supplementation or haemostatic treatment, whether TSH has been corrected, and whether vitamin D levels are improving. The comparison tool allows any two tests to be placed side by side — useful for demonstrating to a gynaecologist that ferritin has fallen significantly over the past year despite supplementation, strengthening the case for escalating treatment beyond watchful waiting.

PDF export means you can bring a complete structured biomarker history to every appointment — gynaecology, haematology, GP, or pre-operative assessment — ensuring that the severity and trajectory of anaemia is visible to every member of your care team. The blood test frequency tool can assist with planning a monitoring schedule appropriate to your current treatment stage. The complete blood test guide provides useful background on what a comprehensive panel should include when managing heavy period-related anaemia.

Medical disclaimer: Health3 is a biomarker tracking and educational tool, not a medical device. Decisions about fibroid treatment — including medical management, uterine artery embolisation, myomectomy, or hysterectomy — must be made with a qualified gynaecologist based on fibroid size, location, symptom severity, and your individual fertility and health goals. Do not adjust iron supplementation or any other medication based on Health3 data without consulting your treating clinician.

Key Biomarkers to Track

Health Topics That Matter Most

• Iron & Anemia — Fibroid-related heavy menstrual bleeding is among the most common causes of iron deficiency anaemia; ferritin and iron tracking quantifies severity and monitors the response to treatment.
• Hormonal Balance — Fibroids are oestrogen-sensitive; thyroid status and other hormonal influences on menstrual pattern are relevant to the clinical picture and worth tracking alongside iron markers.
• Bone Health — Women on GnRH agonist therapy for fibroids face temporary bone density reduction; calcium and vitamin D monitoring supports bone health during treatment.
• Energy & Fatigue — Fatigue in women with fibroids is predominantly iron-driven; identifying the depth of iron store depletion through ferritin tracking connects blood data to energy and quality of life outcomes.

How Health3 Helps

• Biomarker Trending: Track how your biomarker values change over time with visual trend charts. Spot patterns that single snapshots miss.
• Test Comparison: Compare two blood tests side by side to see exactly what changed between draws.
• Optimal vs Normal Ranges: See whether your values are merely normal or truly optimal. Health3 distinguishes between standard lab ranges and evidence-based optimal ranges.
• Weekly Insights: Receive personalized, science-backed insights each week based on your latest biomarker values.
• PDF Export: Export your test results and full history as clean, branded PDF reports to share with your doctor.

Track Your Biomarkers With Health3

Scan your lab results, explore biomarker interactions, and track trends over time with the Health3 app.